WeVote
Log In

Bill

Bill

A 1809

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

2024-2025 Regular Session Introduced by Linda Carter and 6 co-sponsors

New Jersey bill creates sickle cell trait registry and requires genetic counseling and public outreach to improve disease surveillance and health equity.

Introduced in the Assembly, Referred to Assembly Health Committee
#disease #humansvcs
0
WeVote Research Nonpartisan
Bill Summary · A 1809

Legislative bill overview

Bill A 1809 creates a centralized database to record sickle cell trait diagnoses across New Jersey and mandates public information campaigns and genetic counseling services related to sickle cell conditions. The registry would consolidate diagnostic data that is currently scattered across various healthcare providers and testing facilities.

Why is this important

Sickle cell trait affects approximately 1 in 12 African Americans and carries health implications for carriers and their descendants. A centralized registry could improve public health surveillance, enable targeted outreach to affected populations, and facilitate access to genetic counseling—information crucial for family planning and preventive care decisions. The bill acknowledges that fragmented data collection limits the state's ability to address health disparities affecting communities disproportionately impacted by sickle cell disease.

Potential points of contention

  • Privacy and consent concerns: Creation of a genetic registry raises questions about data security, who can access the information, whether individuals must opt-in or opt-out, and protections against potential discrimination by insurers or employers.
  • Funding and implementation costs: Establishing and maintaining a statewide registry, providing counseling services, and conducting outreach campaigns require ongoing resources; the bill's fiscal impact and funding source aren't specified in this summary.
  • Medical autonomy and testing protocols: Determining which tests trigger registry enrollment, whether participation is voluntary or mandatory for certain populations, and clinical standards for diagnosis and counseling could generate debate among healthcare providers.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.